title: Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma.
authors.forename: D
authors.initials: D
authors.lastname: Biotti
authors.forename: A
authors.initials: A
authors.lastname: Viaccoz
authors.forename: N
authors.initials: N
authors.lastname: Olivier
authors.forename: C
authors.initials: C
authors.lastname: Tilikete
authors.forename: V
authors.initials: V
authors.lastname: Rogemond
authors.forename: J
authors.initials: J
authors.lastname: Honnorat
authors.forename: A
authors.initials: A
authors.lastname: Vighetto
mesh_terms: D000230:Adenocarcinoma / Q000150:complications* / Q000473:pathology; D000951:Antigens, Neoplasm / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology; D001921:Brain / Q000473:pathology; D006801:Humans; D020363:Limbic Encephalitis / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000276:immunology*; D015835:Ocular Motility Disorders / Q000209:etiology*; D013274:Stomach Neoplasms / Q000150:complications* / Q000473:pathology
chemical_list: D000951:Antigens, Neoplasm; D001323:Autoantibodies; C119249:Ma2 antigen; D009419:Nerve Tissue Proteins